131 related articles for article (PubMed ID: 34100973)
1. Safety and efficacy of polydimethylsiloxane (Macroplastique®) in women with stress urinary incontinence: analysis of data from patients who completed three years follow-up.
Ghoniem G; Farhan B; Chowdhury ML; Chen Y
Int Urogynecol J; 2021 Oct; 32(10):2835-2840. PubMed ID: 34100973
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes With Macroplastique in Women With Stress Urinary Incontinence Secondary to Intrinsic Sphincter Deficiency.
Kusin SB; Carroll TF; Alhalabi F; Christie AL; Zimmern PE
Urology; 2024 Mar; 185():36-43. PubMed ID: 38199277
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Macroplastique injections for stress urinary incontinence after suburethral sling removal.
Rodríguez D; Carroll T; Alhalabi F; Carmel M; Zimmern PE
Neurourol Urodyn; 2020 Mar; 39(3):994-1001. PubMed ID: 32068306
[TBL] [Abstract][Full Text] [Related]
4. Does the Polydimethylsiloxane Urethral Injection (Macroplastique
Serati M; Braga A; Scancarello C; De Rosa A; Frigerio M; Baruch Y; Torella M; Salvatore S; Ruffolo AF
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984580
[No Abstract] [Full Text] [Related]
5. Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency.
Carroll TF; Christie A; Foreman M; Khatri G; Zimmern PE
Int Braz J Urol; 2019; 45(5):989-998. PubMed ID: 31626522
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of polydimethylsiloxane injection (Macroplastique
Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F;
BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026
[TBL] [Abstract][Full Text] [Related]
7. Durability of Macroplastique volume and configuration in women with stress urinary incontinence secondary to intrinsic sphincter deficiency: A retrospective review.
Carroll TF; Christie A; Foreman M; Kuprasertkul A; Khatri G; Zimmern PE
Low Urin Tract Symptoms; 2021 Jul; 13(3):335-340. PubMed ID: 33354906
[TBL] [Abstract][Full Text] [Related]
8. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study.
Ghoniem G; Corcos J; Comiter C; Bernhard P; Westney OL; Herschorn S
J Urol; 2009 Jan; 181(1):204-10. PubMed ID: 19013613
[TBL] [Abstract][Full Text] [Related]
9. Bladder neck and urethral erosions after Macroplastique injections.
Rodríguez D; Jaffer A; Hilmy M; Zimmern P
Low Urin Tract Symptoms; 2021 Jan; 13(1):93-97. PubMed ID: 32783393
[TBL] [Abstract][Full Text] [Related]
10. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.
Bano F; Barrington JW; Dyer R
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(2):147-50; discussion 150. PubMed ID: 15378234
[TBL] [Abstract][Full Text] [Related]
11. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results.
Ghoniem G; Corcos J; Comiter C; Westney OL; Herschorn S
J Urol; 2010 Apr; 183(4):1444-9. PubMed ID: 20171691
[TBL] [Abstract][Full Text] [Related]
12. Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women.
ter Meulen PH; Berghmans LC; Nieman FH; van Kerrebroeck PE
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Feb; 20(2):177-83. PubMed ID: 18936867
[TBL] [Abstract][Full Text] [Related]
13. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial.
Maher CF; O'Reilly BA; Dwyer PL; Carey MP; Cornish A; Schluter P
BJOG; 2005 Jun; 112(6):797-801. PubMed ID: 15924540
[TBL] [Abstract][Full Text] [Related]
14. Effect of the Macroplastique Implantation System for stress urinary incontinence in women with or without a history of an anti-incontinence operation.
Gumus II; Kaygusuz I; Derbent A; Simavli S; Kafali H
Int Urogynecol J; 2011 Jun; 22(6):743-9. PubMed ID: 21461709
[TBL] [Abstract][Full Text] [Related]
15. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
Radley SC; Chapple CR; Mitsogiannis IC; Glass KS
Eur Urol; 2001 Apr; 39(4):383-9. PubMed ID: 11306875
[TBL] [Abstract][Full Text] [Related]
16. Macroplastique implantation system for the treatment of female stress urinary incontinence.
Tamanini JT; D'Ancona CA; Tadini V; Netto NR
J Urol; 2003 Jun; 169(6):2229-33. PubMed ID: 12771756
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and treatment of Macroplastique® urethral exposures: a retrospective case series.
Ramirez-Caban L; Malekzadeh M; Ossin DA; Hurtado EA
Int Urogynecol J; 2022 Mar; 33(3):681-687. PubMed ID: 34213601
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence.
Ghoniem GM; Miller CJ
Int Urogynecol J; 2013 Jan; 24(1):27-36. PubMed ID: 22699885
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intrinsic sphincter deficiency using the Macroplastique Implantation System: two-year follow-up.
Tamanini JT; D'Ancona CA; Netto NR
J Endourol; 2004 Nov; 18(9):906-11. PubMed ID: 15659931
[TBL] [Abstract][Full Text] [Related]
20. The role of macroplastique implantation in the management of occult urinary stress incontinence.
Montera R; Scaletta G; Plotti F; Lopez S; Luvero D; Capriglione S; Aloisi A; Gatti A; De Cicco Nardone C; Carassiti R; Terranova C; Angioli R
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():124-128. PubMed ID: 29704816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
